AXA1125 – A New Mitochondrial Enhancer Is Being Trialed in Long COVID

I have a feeling that interesting treatment trials for long COVID may become a regular blog topic on Health Rising. That would be a nice change. Treatment trials have been chronic fatigue syndrome’s Achilles heel. Except for cognitive behavioral therapy (CBT) and graded exercise therapy (GET), which have dominated the … Continue reading AXA1125 – A New Mitochondrial Enhancer Is Being Trialed in Long COVID